Recalls / Active ingredient / Mepolizumab
Mepolizumab
1 FDA drug recall involving the active ingredient “Mepolizumab”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2019-09-06 | Class II | Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, | Cardinal Health dba Specialty Pharmaceutical Services |